Philadelphia is a city steeped not only in the history represented by its Historic District with Independence Hall and the Liberty Bell, but also steeped in medical history – the birthplace of American medicine and home to the nation’s first medical school, first children’s hospital, first college of pharmacy, first medical library and first hospital.
The city is home to a host of medical, biotechnology, pharmaceutical, higher education, research and venture capital entities that can provide access to a deep pool of talent and partners for life sciences meetings and conventions.
We have seven medical schools, 22 nursing schools, two dental schools, three colleges of pharmacy, a veterinary school, a school of optometry, a podiatry school, allied health schools and almost 100 hospitals and more than 90 colleges and universities in our region.
PHL Life Sciences, a division of the Philadelphia Convention & Visitors Bureau (PHLCVB), connects the tri-state’s (Pennsylvania, New Jersey and Delaware) life sciences leaders representing medical, biotechnology, pharmaceutical, higher education, research, venture capital and the healthcare industries to collaborate and brand the Philadelphia region as “America’s Life Sciences Meetings Destination.”
Our Mission is to raise the visibility of the tri-state area as a leader in the Life Sciences and as a world-class destination for the industry’s meetings, conventions and business opportunities.
The PHL Life Sciences Ultimate Solution Award will be presented to Christopher Yochim, Chair of Delaware BIO, on September 20, 2018, for his leadership in the Greater Philadelphia life sciences community.
Yochim spent 35 years at AstraZeneca, creating partnerships and overseeing global external relations for the organization. As a founding member of the Delaware Bioscience Association, he has been instrumental in coalescing resources at the state level in order to attract and retain life sciences and pharmaceutical businesses. This has had a profound impact on the Delaware Valley, strengthening the region’s ties to the private sector and giving Philadelphia an edge when attracting major conventions, such as BIO International, which returns in 2019.
Yochim’s current role is a head of Business Development for the NIIMBL National Institute for Innovation in Manufacturing Biopharmaceuticals. NIIMBL is a national consortium of academia and industry. Its goal is to bring innovative solutions to real world challenges in manufacturing biological therapeutics.
Previous winners of the award include Former Philadelphia Mayor Michael Nutter (2015), American Association for Cancer Research (AACR) CEO Margaret Foti, Ph.D. (2016), and LabCorp CEO David King (2017).